Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study

British Journal of Clinical Pharmacology
Wen-Hsuan HouHuang-Tz Ou

Abstract

The aim of this study was to investigate the putative link between dipeptidyl peptidase-4 inhibitor (DPP-4i) use and the risk of fracture in patients with type 2 diabetes. This propensity-score-matched population-based cohort study was performed between 2009 and 2013 on patients with type 2 diabetes who were stable metformin users. A total of 3996 patients with type 2 diabetes used DPP-4i as a second-line antidiabetic drug. The same number of matched non-DPP-4i users were followed up until fracture occurrence, health insurance policy termination, or the end of 2013. The incidence rates of overall and cause-specific fractures were estimated based on the Poisson assumption. A multiple Cox proportional hazard model was used to estimate the covariate-adjusted hazard ratio (HR) and 95% confidence interval (CI) to determine the association between DPP-4i use and overall and cause-specific fractures stratified by age and sex. Over a maximum follow-up period of 5 years, 340 DPP-4i users and 419 non-DPP-4i users were newly diagnosed with fractures, yielding incidence rates of 28.03 and 32.04 per 1000 people per year, respectively. The Cox proportional hazard model revealed that DPP-4i use significantly reduced the risk of all-cause frac...Continue Reading

References

Nov 1, 1994·Journal of Clinical Epidemiology·M CharlsonJ Gold
Feb 12, 1998·Annals of Internal Medicine·D B Rubin
Jul 2, 1999·Diabetes Care·J T TuominenT Rönnemaa
Jun 26, 2001·Diabetes Care·R Q IversUNKNOWN Blue Mountains Eye Study
May 11, 2004·Diabetes/metabolism Research and Reviews·Vincenzo CarnevaleEmilio D'Erasmo
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Mar 17, 2007·Diabetes Care·Subhashini YaturuSushil K Jain
Dec 25, 2007·Gender Medicine·Piet Geusens, Geertjan Dinant
Aug 2, 2008·Diabetes, Obesity & Metabolism·Andrew Grey
Dec 17, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Yoon K LokeCurt D Furberg
Mar 21, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity·Peter Vestergaard
Jul 10, 2009·Regulatory Peptides·Bernardo Nuche-BerenguerMaría L Villanueva-Peñacarrillo
Oct 13, 2009·European Journal of Internal Medicine·Navdha RamchurnClive Kelly
Dec 31, 2009·American Journal of Physiology. Endocrinology and Metabolism·C SanzE Blázquez
Jun 16, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·C H ChangL M Chuang
Jun 16, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·D J Betteridge
Feb 2, 2013·Diabetes, Obesity & Metabolism·A Montagnani, S Gonnelli
Jun 19, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Helena JohanssonM Carola Zillikens
Sep 3, 2013·The New England Journal of Medicine·Benjamin M SciricaUNKNOWN SAVOR-TIMI 53 Steering Committee and Investigators
Sep 12, 2013·Diabetes/metabolism Research and Reviews·Emily Jane GallagherDerek LeRoith
Feb 15, 2014·American Journal of Public Health·Diane FeskanichWalter C Willett
Mar 19, 2014·Journal of Bone and Mineral Metabolism·Sahar Kamal Hegazy
Jul 24, 2014·American Journal of Physiology. Endocrinology and Metabolism·Lorenzo GlorieAnja Verhulst
Jul 18, 2015·Pharmacoepidemiology and Drug Safety·Johanna H M DriessenAndrea M Burden
Apr 16, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H J ChoiC S Shin
Jun 21, 2016·Diabetes Research and Clinical Practice·Jil MamzaIskandar Idris
Oct 26, 2016·British Journal of Clinical Pharmacology·Johanna H M DriessenRonald M A Henry
Dec 13, 2016·Diabetes, Obesity & Metabolism·Johanna H M DriessenFrank de Vries
Jun 13, 2017·The New England Journal of Medicine·Bruce NealUNKNOWN CANVAS Program Collaborative Group
Oct 22, 2017·British Journal of Pharmacology·Stephen Ph AlexanderUNKNOWN CGTP Collaborators

❮ Previous
Next ❯

Citations

Sep 20, 2018·Endocrinology and Metabolism·Jakob Starup-LindeBente Lomholt Langdahl
May 28, 2019·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·K HidayatB-M Shi
Sep 15, 2020·BioMed Research International·Jiawei QiItaru Mizoguchi
Sep 17, 2019·World Journal of Diabetes·Silvia Costantini, Caterina Conte
Nov 10, 2020·Current Osteoporosis Reports·Z Al-MashhadiJakob Starup-Linde
Feb 18, 2021·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B R YangK-H Shin
Jul 3, 2021·International Journal of Molecular Sciences·Hideki KitauraItaru Mizoguchi
May 28, 2019·Journal of Medicinal Chemistry·Chao ZhaoJun Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.